Discovery and development
Innovation centers in China and the United States support drug discovery and clinical development.
Partnering
We work with partners to advance research programs and bring medicines to patients in additional markets.

Discuss rights to a specific asset, indication or territory.
Explore distribution, market access and regional commercial partnerships.
Discuss shared clinical development plans for a candidate or indication.
Discuss supply and manufacturing requirements with the relevant teams.
Explore a research collaboration around a target, modality or program.
Innovation centers in China and the United States support drug discovery and clinical development.
Two commercial facilities in China support biologics production and clinical supply.
Territory-specific collaborations support the development and commercialization of medicines such as toripalimab.
Explore selected announced collaborations, including their original scope and announcement year.
Agreed to collaborate on neutralizing antibodies for COVID-19, including the candidate later named etesevimab.
Read the announcementAnnounced a collaboration for toripalimab development and commercialization in the United States and Canada.
Read the announcementAgreed to distribute and market toripalimab in European territories. TopAlliance Biosciences Europe retained the marketing authorization.
Read the announcementAnnounced a collaboration to develop and commercialize toripalimab in India, South Africa and selected Latin American markets.
Read the announcementLicensed rights to develop and commercialize toripalimab in specified Middle East and North Africa markets.
Read the announcementFor partnering inquiries, call our Shanghai headquarters and ask for Business Development.
+86 21 6105 8800